BioSpace News Archive

iOnctura SA, a late stage preclinical immuno-oncology company, announced today that its abstract (abstract # 1781) entitled “Preclinical development of a novel, highly selective PI3Kδ inhibitor, IOA-244, for the treatment of solid malignancies” has been selected for an oral presentation at the American Association for Cancer Research Annual Meeting 2019 which will take place from 29th March to 3rd April in Atlanta, Georgia, USA.

Amryt, a revenue generating orphan drug company focused on acquiring, developing & commercialising products that help to improve the lives of patients where there is a high unmet medical need, today announces an update on its pivotal Phase III EASE trial for AP101 as a potential treatment for Epidermolysis Bullosa (“EB”).

The summit will feature expert faculty from the Rush University Medical Center

When Auburn University senior Cassie Bebout was 6 years old, her 9-year-old brother Jake died from GM1, a rare genetic disease with no cure.

General Manager of Healthcare at FairWarning Invited to Participate in Panel to Help Covered Entities Navigate Regulatory Requirements with New Business Associates

Upgrades to Award-Winning Orbita Voice™ Platform Deliver Enterprise-Grade, End-to-End Functionality to Design, Build, Manage and Optimize Conversational Experiences

USDA Organic certification of its hemp crop and a vertically integrated seed-to-shelf process allows leading CBD brand to offer consumers the highest quality products at a great value.

Scientific presentations on cladribine tablets include analysis on durability of NEDA (no evidence of disease activity) status and safety analysis with up to 10 years of follow-up data in some patients

LTSS Software Enables Community Service Providers and Home Health Agencies to Document Supports for Older Adults

Exude, Inc., an insurance and human capital consulting firm, recently launched a new benefits product which has been endorsed by The Alliance of Community Service Providers.